Chubb Limited logo

Chubb LimitedNYSE: CB

Financials · Property & Casualty Insurance

$323.99

-1.21%

Vol: 1.2M

Research Digest

Friday, June 19, 2026

Neutral

No significant overnight updates

No material news in the last 48 hours.

Price 50d 200d

Previous Market Intelligence

13 days
Jun 18Chubb authorized a new $7.5 billion share repurchase program and raised its annual dividend 5.2% to $4.08 per share, extending its 33-year dividend growth streak.Positive

Chubb Limited (CB) shareholders approved a 5.2% increase in the annual dividend to $4.08 per share at the May 21 annual meeting, extending the company's 33-consecutive-year dividend growth streak. The first quarterly installment of $1.02 per share will be paid July 2, 2026, to holders of record June 12. The Board also authorized a new $7.5 billion share repurchase program effective July 1, 2026. On June 4, Chubb issued Senior Notes due 2031 and 2033 as part of routine debt management. Chubb reported a Q1 2026 combined ratio of 84%, consistently outperforming peers. Piper Sandler raised its price target to $340 and Wells Fargo raised its target to $333, both maintaining neutral-equivalent ratings. The stock last closed at $326.95 on June 16.

Jun 17No significant overnight updatesNeutral

No material news in the last 48 hours.

Jun 16No significant overnight updatesNeutral

No material news in the last 48 hours.

Jun 15Barclays cut its Chubb price target to $368 from $375, warning P&C insurance earnings upside is getting harder to find as pricing softens.Negative

On June 12, 2026, Barclays lowered its price target on Chubb to $368 from $375 while reiterating an Equal Weight rating, cautioning that earnings upside across the property and casualty insurance sector is 'becoming harder to find' as pricing softens, growth slows, and margin pressure builds. The downgrade in target reflects a broader cautious read on the P&C cycle rather than a Chubb-specific stumble; the company's Q1 2026 core operating EPS of $6.82 beat consensus and net premiums written grew 10.7%. For context, on May 26 Piper Sandler had raised its target to $340 (Neutral). The consensus across 25 analysts remains Buy. The risk highlighted is decelerating pricing power and margin compression as the hard insurance market fades; next earnings are due July 28, 2026.

Jun 14No significant overnight updatesNeutral

No material news in the last 48 hours.

May 21Chubb priced a $1 billion 5.30% senior notes offering due 2036 on May 18, 2026 with AM Best assigning a strong 'a+' rating to the new notes.Neutral

On May 18, 2026, Chubb Limited announced that its subsidiary Chubb INA Holdings LLC priced a public offering of $1 billion in 5.30% senior notes due 2036. The notes are guaranteed by Chubb Limited and proceeds are slated for general corporate purposes including potential debt refinancing. AM Best assigned a strong 'a+' rating, reflecting confidence in Chubb's financial stability. Chubb also released its 2026 Cyber Claims Report, which found that average cyber insurance claim severity for businesses with $1 billion+ in revenue nearly doubled to about $4.4 million in 2025 from roughly $2.2 million in 2024. CB shares closed at $328.38 on May 20.

May 20Chubb priced a $1B senior notes offering and won regulatory approval (alongside Berkshire) to drop AI-related coverage from corporate policies.Mixed

Chubb INA Holdings priced a public offering of $1B in 5.30% senior notes due 2036 for general corporate purposes, including potential debt repayment/refinancing, strengthening the company's capital flexibility. In parallel, Chubb and Berkshire Hathaway won state regulatory approval to drop AI-related damages from corporate insurance policies, materially reducing tail risk from the rapidly evolving AI liability landscape. Q1 2026 produced record net premiums written of $14.0B (+10.7%), core operating income up 85.2% to $6.82/share, though headline EPS of $5.88 missed consensus despite strong YoY growth. Management also continues to intentionally shrink large account and E&S lines where pricing is inadequate. Shares are down ~2% over the past week. Risk: catastrophe loss volatility and ongoing underwriting discipline could weigh on near-term top-line growth.

May 19Chubb prices $1B 5.30% senior notes due 2036, expands cancer care insurance and Hong Kong bond issuanceMixed

On May 18, Chubb's subsidiary Chubb INA Holdings priced a $1B offering of 5.30% senior notes due 2036, fully guaranteed by Chubb, with proceeds for general corporate purposes including debt repayment. Chubb expanded its product offerings with the launch of new cancer care insurance in Canada while also issuing senior unsecured bonds in Hong Kong. Shares have pulled back, with the stock down ~2% over the past week, ~4% over the past month, and ~5% over the past 3 months, closing at $325.12 on May 5. Q1 2026 saw strong returns with steady underwriting margins and rising investment income, and analysts project a 75.5% YoY jump in quarterly EPS. The board signaled its intent to recommend a 33rd consecutive annual dividend increase at the 2026 AGM. Risk: analyst price-target dispersion and projected 3-year decline in earnings/revenue have raised valuation concerns.

May 18Chubb CEO Evan Greenberg warns 'arms race is on' as Anthropic Mythos AI lowers cyberattack threshold for middle-market firms.Mixed

In a May 18, 2026 Insurance Journal interview, Chubb CEO Evan G. Greenberg said the 'arms race is on' regarding Anthropic's Mythos AI model, which has lowered the threshold for cyber vulnerability, and identified middle-market organizations as the 'biggest meatball' target for cyber attacks. The comments come as Berkshire Hathaway and Chubb received approval to exclude AI-related damages from standard liability policies, a notable shift in insurance industry posture toward AI risk. Chubb's stock closed at $324.15 on May 15, with shares trading between $321.36 and $325.82 on May 16, down about 2% over the past week. Wells Fargo analyst Elyse Greenspan raised the price target on Chubb to $333 from $321 with an Equal Weight rating. The company is also launching a new cancer care insurance product in Canada and issuing senior unsecured bonds in Hong Kong.

May 15Chubb to recommend 33rd consecutive annual dividend increase to $4.08/share after strong Q1 net premiums up 10.7%Mixed

Chubb's board announced plans to recommend a 33rd consecutive annual dividend increase at the 2026 AGM, lifting the quarterly dividend to $1.02/share ($4.08 annualized) from $0.97. Q1 2026 results showed core operating EPS of $6.82 (up 85.2%), consolidated net premiums written of $14.0B (up 10.7%), and net income of $2.32B (up over 70% YoY). Management is deliberately pulling back from softening shared and layered property markets where rates dropped 25-40%, declining underwriting that no longer meets return thresholds. Despite the EPS beat, shares have declined ~5% over three months on property-market softening concerns. The company also received an 'a+' credit rating on its bond offerings and launched a new cancer-care insurance product. Risk: continued property rate softening could pressure premium growth into 2H 2026.

May 14Chubb shares slid into a $315-$324 trading range on May 14 as investors weighed signs of a softening property insurance market against a 'Buy' consensus 12-month price target of $332.76.Mixed

On May 14, 2026, Chubb traded between a low of $315.04 and a high of $324.51, after closing $325.12 on May 5, reflecting roughly a 1% monthly decline. Twenty-one analysts maintain an average 'Buy' rating with a 12-month target of $332.76, but investors are increasingly cautious as competition rises and property insurance rates decline. The company's Q1 2026 results showed core operating earnings of $2.7 billion and net premiums up 10.7%, with full-year 2025 revenue of $59.63 billion (+6.52%) and earnings of $10.31 billion (+11.19%). This matters because Chubb's premium-pricing power has been the core of its bull thesis, and a softer P&C cycle compresses underwriting margins. The risk is that further rate softening forces analysts to trim 2026 estimates and price targets.

May 13Chubb formed alliance with Verified Clinical Trials for clinical research risk management; Q1 2026 core operating earnings of $2.7B with premiums up 10.7%.Mixed

Chubb reported Q1 2026 core operating earnings of $2.7B with net premiums up 10.7%, showing robust growth in premiums, earnings, and book value with strong underwriting and investment results. Management remains confident in continued double-digit EPS and tangible book value growth despite macro uncertainties. The company announced a strategic alliance with Verified Clinical Trials to support risk management and data quality in clinical research, focusing on research subject safety, data integrity, and reducing operational and regulatory risks. CB closed at $325.12 on May 5 and trades at $321.28, about 7% below the analyst price target of $345.26. Investors are spooked by signs of softening property insurance market.

May 12Chubb shares traded in $318-$324 range early-week with no fresh material catalyst inside the 48-hour window; recent focus remains on softening P&C pricing flagged by CEO Greenberg.Neutral

No significant overnight or pre-market catalyst in the last 48 hours. Recent context (outside the strict 48h window) includes Q1 2026 EPS of $6.82 versus $6.60 consensus, P&C underwriting income of $1.79 billion, and a planned 33rd consecutive annual dividend increase to be recommended at the 2026 AGM. CEO Evan Greenberg has publicly criticized aggressive industry price-cutting as 'dumb,' and investors remain cautious about softening property insurance rates. The stock recently traded around $319-$325.

Sector Peers

CompanyPriceDay1MFwd P/EBetaMkt Cap
CBCHUBB$323.99-1.21%-1.5%11.1x0.42$125.4B
PGRPROGRESSIVE$203.88-0.26%+1.1%12.6x0.27$119.5B
TRVTRAVELERS$307.22+0.37%+0.3%10.8x0.49$65.5B
ALLALLSTATE$220.59-0.48%-0.4%8.4x0.19$56.9B
HIGHARTFORD$128.21-1.10%-6.2%9.1x0.47$35.2B
ACGLARCH$91.21-1.26%-5.8%9.2x0.31$31.9B

Key Fundamentals

Market Cap$125.4B
P/E (TTM)11.4
Forward P/E11.1
Beta0.42
Div Yield124.00%
Prev Close$327.96

RSI (14-Day)

51Neutral
0305070100

52-Week Range

$264.10$323.99$345.67
From High-6.3%
From Low+22.7%

Moving Averages

50d SMA
$326.64-0.8%
200d SMA
$303.34+6.8%

Price between 50d and 200d. Testing 50d support.

Historical Returns

1W
-1.3%
1M
-0.4%
3M
-2.0%
6M
+9.6%
1Y
+11.7%
YTD
+4.8%

Volume

Today1.2M
20d Avg1.2M
Ratio1.00x